Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,152,050
-
Share change
-
-132,469
-
Total reported value
-
$925,096
-
Price per share
-
$0.43
-
Number of holders
-
20
-
Value change
-
-$70,354
-
Number of buys
-
5
-
Number of sells
-
7
Institutional Holders of MOLECULIN BIOTECH INC - COM (MBRX) as of Q3 2023
As of 30 Sep 2023,
MOLECULIN BIOTECH INC - COM (MBRX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,152,050 shares.
The largest 10 holders included
VANGUARD GROUP INC, Sio Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, NORTHERN TRUST CORP, MILLENNIUM MANAGEMENT LLC, SCHMIDT P J INVESTMENT MANAGEMENT INC, and Sigma Planning Corp.
This page lists
20
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.